Gianoulakis, Christina
Le Centre de Recherche Douglas,
Canada
2025 Rank: 53901
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 174 out of 17312 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53901 | 59425 |
| Total Cites | 3717 | 4169 |
| H-index | 39 | 39 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 986 | 1021 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1752 | 1866 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3383 | 3717 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2212 | 2346 |
| Ratio of Total Citations to Distinct Citing Papers | 1.68 | 1.78 |
| Self-Citation Percentage |
10.84%
|
|
Gianoulakis, Christina
Université McGill,
Canada
2024 Rank: 50660
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 173 out of 16370 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50660 | 55251 |
| Total Cites | 3640 | 4090 |
| H-index | 38 | 39 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 961 | 996 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1710 | 1824 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3316 | 3648 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2159 | 2292 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.78 |
| Self-Citation Percentage |
11.00%
|
|
Gianoulakis, Christina
Université McGill,
Canada
2023 Rank: 46740
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 155 out of 15589 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46740 | 51205 |
| Total Cites | 3572 | 4021 |
| H-index | 38 | 39 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 947 | 982 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1688 | 1802 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3261 | 3593 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2112 | 2244 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.79 |
| Self-Citation Percentage |
11.17%
|
|
Gianoulakis, Christina
Université McGill,
Canada
2022 Rank: 43382
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 138 out of 14534 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43382 | 46769 |
| Total Cites | 3454 | 3901 |
| H-index | 37 | 39 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 920 | 955 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1646 | 1760 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3166 | 3498 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2032 | 2163 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.80 |
| Self-Citation Percentage |
11.46%
|
|
Gianoulakis, Christina
Université McGill,
Canada
2021 Rank: 41307
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 139 out of 13890 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41307 | 44424 |
| Total Cites | 3357 | 3800 |
| H-index | 37 | 39 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 906 | 941 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1609 | 1723 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3081 | 3410 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1979 | 2108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.80 |
| Self-Citation Percentage |
11.66%
|
|
Gianoulakis, Christina
McGill University,
Canada
2020 Rank: 38000
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Psychiatry
Rank in SubField 1: 138 out of 12500 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38000 | 40724 |
| Total Cites | 3219 | 3653 |
| H-index | 37 | 39 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 871 | 906 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1556 | 1669 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 2965 | 3293 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1890 | 2015 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.81 |
| Self-Citation Percentage |
11.88%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.